Ayurcann Holdings Corp.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Igal Sudman
- Full Time Employees
- 5
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 1080 Brock Road Pickering ON Canada L1W 3X4
- IPO Date
- Nov 21, 2014
- Website
- ayurcann.com
- Similar Companies
- Business
- Ayurcann Holdings Corp. stands as a key player in the Canadian cannabis sector, providing extensive post-harvest solutions to licensed producers throughout the country. The company offers a complete suite of services, including specialized extraction and refining processes, sales of bulk distillate oil, diverse product formulation, and white-label manufacturing for an array of cannabis derivatives. This encompasses popular product formats like vapes, tinctures, topicals, pre-rolls, concentrates, and various extracts, alongside tailored packaging solutions, efficient inventory management, and robust fulfillment and distribution networks. In addition to its business-to-business support, Ayurcann has successfully carved out a significant presence in the Canadian recreational market through its proprietary brands, such as Fuego, XPLOR, and Happy and Stoned. These products are broadly distributed across numerous Canadian provinces, including Ontario, British Columbia, Alberta, Saskatchewan, Manitoba, New Brunswick, and Yukon. The firm's products are accessible in over 75% of licensed retail cannabis stores nationwide, with a notable leadership position in Ontario, where it ranks among the leading vape producers by volume. The company also operates the Ayurcann Marketplace, an online platform dedicated to providing medical cannabis products to consumers. Operating from a fully licensed 13,585-square-foot extraction and manufacturing facility in Pickering, Ontario, Ayurcann has demonstrated strong financial performance, reporting record gross revenues of $55.4 million for the fiscal year that concluded on June 30, 2025, marking a 21% increase over the previous year. While the company voluntarily delisted from the OTCQB Venture Market on October 30, 2025, its shares continue to be traded on the Canadian Securities Exchange under the symbol "AYUR". Established in 2018, Ayurcann Holdings Corp. maintains its headquarters in Pickering, Canada.
Auxly Provides Update on Stalking Horse Bid for Ayurcann
AYURCANN REPORTS Q1 2026 SALES OF $14,638,697
AYURCANN REPORTS FISCAL YEAR 2025 RECORD SALES OF $55,446,352 IN GROSS REVENUE, FEATURING 21% YEAR-OVER-YEAR INCREASE AND PROVIDES CORPORATE UPDATE
AYURCANN REPORTS ANOTHER RECORD SALES GROWTH IN Q2 2025 OF $13,363,509
AYURCANN REPORTS ANOTHER RECORD SALES GROWTH IN Q1 2025 OF $14,760,268 AND PROVIDES CORPORATE UPDATE
AYURCANN TERMINATES BUSINESS COMBINATION
AYURCANN REPORTS FISCAL YEAR 2024 RECORD SALES OF $45,265,235 IN GROSS REVENUE, FEATURING ANOTHER 100% YEAR-OVER-YEAR INCREASE
Ayurcann Holdings Corp is entering into a business combination with Arogo Capital Acquisition Corp. and its subsidiaries at a combined enterprise value estimated to be U.S. $210 million.
AYURCANN REPORTS RECORD SALES IN Q3 2024 OF $11,655,360 FEATURING A 97% INCREASE IN GROSS REVENUE
AYURCANN REPORTS RECORD SALES IN Q2 2024 FEATURING A 141% INCREASE IN GROSS REVENUE
Ayurcann Provides a Corporate Update, Completes Debt Settlement and Grants Options and RSUs
AYURCANN ANNOUNCES AGSM RESULTS
AYURCANN REPORTS RECORD SALES IN Q1 2024 FEATURING A 249% INCREASE IN GROSS REVENUE
AYURCANN REPORTS 2023 FINANCIAL RESULTS FEATURING $22,371,604 IN GROSS REVENUE
AYURCANN HOLDINGS CORP. PROVIDES CORPORATE UPDATE, AND GROWTH STRATEGY
Ayurcann Holdings enters agreement to acquire 100% of Joints and Hustle & Shake for $5.5M
Ayurcann Holdings sees fiscal 3Q revenue rise to $2.8M as it gains more traction in the market
Ayurcann Holdings says it has received its flower sales license amendment from Health Canada effective April 19, 2022